VentureCapital

The VC Factor:  Data-driven Insights Into European VC And Its Resilience To The COVID-19 Crisis

To access the entire article click here.


European venture capital is on a roll. Across the continent, venture capital firms are identifying and helping to fuel businesses that are positively disrupting sectors, creating ground-breaking software and robotics, and developing treatments for life threatening conditions like cancer. More than that, venture capital is supporting an ecosystem that is powering Europe’s economic competitiveness and driving the continent towards a more sustainable long-term future.


2020 was a challenging year for people, companies and countries cross Europe. European venture capital did not escape the effects of COVID-19 but responded with characteristic strength. The industry secured another year of investment growth as funding for European start-ups and scale-ups rose for the eighth year running to €12 billion. Moreover, as this report clearly illustrates, investment flowed across the continent – from London, Paris and Berlin to Catalonia, Copenhagen and Dublin. Europe is packed with entrepreneurial talent and populated throughout with hubs that are driving start-up excellence.


To access the entire article click here.



Send The Author A Message
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates

Subscribe to our FREE DAILY newsletter

Please Select Industry Primary Role*
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.